logo-loader
AIM:SNG OTC:SYGGF

Synairgen PLC

Receive alerts
Market:
AIM
Price
4.75 GBX
Day Change
-7.41%
Market Cap:
£9.57 m
52 weeks high
17.50
52 weeks low
4.00

In brief

Synairgen PLC is a UK-based respiratory company focused on drug discovery and the development of SNG001 (inhaled interferon beta) as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs for severe viral lung infections.

Snapshot

  • Synairgen appoints new CFO as incumbent bows out after nearly 20 years
  • Demand for healthcare stocks similar to late 90s tech boom, says analyst
  • Synairgen reaffirms dedication to key asset, says broker
  • Synairgen looking beyond COVID in fight against respiratory illness